Zobrazeno 1 - 10
of 2 238
pro vyhledávání: '"metabolic dysfunction–associated steatotic liver disease"'
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 17, Pp 4735-4747 (2024)
Yan Han,1,2,* Jinhan Liu,2,3,* Wenjian Li,4 Fan Zhang,1,2 Yonghua Mao1,5 1Department of Endocrinology, Changzhou Third People’s Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, People’s Republic of China
Externí odkaz:
https://doaj.org/article/6025eee0f7af482abdc40dec3a0b9929
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract There are no studies discussing the significance of neutrophil-to-lymphocyte ratio (NLR), neutrophil-percentage-to-albumin ratio (NPAR), and systemic immune-inflammation index (SII) in predicting poor prognosis in patients with metabolic dys
Externí odkaz:
https://doaj.org/article/01c6dcfccf4a458091cccfc3865df0b2
Publikováno v:
Clinical Diabetes and Endocrinology, Vol 10, Iss 1, Pp 1-19 (2024)
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern and the risk of its development is connected with the increasing prevalence of metabolic syndrome (MetS) which occurs as a result of some
Externí odkaz:
https://doaj.org/article/a7550d63464f41babd1ee57f94d7fdb1
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 52, Iss 1, Pp 355-369 (2024)
The global epidemic of metabolic diseases has led to the emergence of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), which pose a significant threat to human health. Despi
Externí odkaz:
https://doaj.org/article/50453e0ef3234c80889052aa0ffa51a5
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Previous studies have shown a positive correlation between the non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol(non-HDLc/HDLc ratio) and metabolism-associated steatohepatitis (MASLD), suggesting it is
Externí odkaz:
https://doaj.org/article/1abddc971f9341a9ab9f61da5787f10b
Autor:
Priti Mishra, Suresh Anand Sadananthan, Jadegoud Yaligar, Kok Hian Tan, Yap Seng Chong, Peter D. Gluckman, Keith M. Godfrey, Marielle V. Fortier, Johan G. Eriksson, Jerry Kok Yen Chan, Shiao-Yng Chan, Dennis Wang, S. Sendhil Velan, Navin Michael
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background It is not clear if conventional liver fat cutoff of 5.56% weight which has been used for identifying fatty liver in western populations is also applicable for Asians. In Asian women of reproductive age, we evaluate the optimum met
Externí odkaz:
https://doaj.org/article/67970fade8a54751814088214b4b0629
Autor:
Ziwen Wang, Mengpei Zhu, Qian Li, Jiali Cao, Qiangqiang Zhong, Ze Jin, Yumei Huang, Qing Lan, Ya Gao, Zhifan Xiong
Publikováno v:
Molecular Medicine, Vol 30, Iss 1, Pp 1-20 (2024)
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease worldwide and few drugs are available for its treatment. Lycorine has effective anti-inflammatory and lipid-lowering effects, but th
Externí odkaz:
https://doaj.org/article/449d5dd84ff4425a96101465cffe4c6d
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Aspartate transaminase-to-platelet ratio index (APRI) is an easy and useful predictor of hepatic fibrosis in patients with chronic hepatic disease, and it significantly correlates with the degree of hepatic fibrosis in adult patie
Externí odkaz:
https://doaj.org/article/98c4f7dc6bfb484c87a217d7ea1a65c5
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Despite the increasing prevalence of nonalcoholic fatty liver disease (NAFLD), the pathophysiology is still not fully understood. Recent evidence suggests that the gut microbiota may play a role in the pathophysiology of NAFLD and
Externí odkaz:
https://doaj.org/article/02871c9d986c4ed98f81caedf00a7606
Autor:
Jaehyun Bae, Eugene Han, Hye Won Lee, Cheol-Young Park, Choon Hee Chung, Dae Ho Lee, Eun-Hee Cho, Eun-Jung Rhee, Ji Hee Yu, Ji Hyun Park, Ji-Cheol Bae, Jung Hwan Park, Kyung Mook Choi, Kyung-Soo Kim, Mi Hae Seo, Minyoung Lee, Nan-Hee Kim, So Hun Kim, Won-Young Lee, Woo Je Lee, Yeon-Kyung Choi, Yong-ho Lee, You-Cheol Hwang, Young Sang Lyu, Byung-Wan Lee, Bong-Soo Cha, on Behalf of the Fatty Liver Research Group of the Korean Diabetes Association
Publikováno v:
Diabetes & Metabolism Journal, Vol 48, Iss 6, Pp 1015-1028 (2024)
Since the role of the liver in metabolic dysfunction, including type 2 diabetes mellitus, was demonstrated, studies on non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) have shown associations
Externí odkaz:
https://doaj.org/article/c79b7897487c464283dfb7105e30c7d7